Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
02/07/1991 | WO1990015069A3 Amino acid derivative anticonvulsant |
02/07/1991 | CA2064024A1 Nucleoside derivatives and their use as medicaments |
02/06/1991 | EP0412061A2 2-(N-acyl)amino-6,7-dimethoxy tetralines, process for their preparation and pharmaceutical compositions having antihypertensive activity containing same |
02/06/1991 | EP0412058A1 1-acyl-2-pyrrolidinones as enhancers of learning and memory and pharmaceutical compositions containing same |
02/06/1991 | EP0412015A1 Derivatives N-(vincristinyl-23) and N-(noranhydro-5-vinblastinyl-23) of amino-1 methylphosphonic acid, their process of preparation and pharmaceutical compositions containing them |
02/06/1991 | EP0412014A1 Benzothiazine derivatives, their preparation and their uses as medicines or as intermediates for the synthesis of medicines |
02/06/1991 | EP0411935A2 Copper radio sensitizers |
02/06/1991 | EP0411912A2 Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders |
02/06/1991 | EP0411909A1 Imidazole compounds and their use as transglutaminase inhibitors |
02/06/1991 | EP0411908A1 Imidazole compounds and their use as transglutaminase inhibitors |
02/06/1991 | EP0411901A2 Treatment of conditions involving excessive eating |
02/06/1991 | EP0411900A2 Medicaments for the treatment of bulimia |
02/06/1991 | EP0411897A2 Avermectin derivatives |
02/06/1991 | EP0411894A2 Azole compounds and their use as transglutaminase inhibitors |
02/06/1991 | EP0411813A1 Optical resolution method for 3S-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4S-chromanol |
02/06/1991 | EP0411775A1 Heterocyclic compounds containing nitrogen and sulfur, processes for their preparation and pharmaceutical compositions thereof |
02/06/1991 | EP0411766A1 Substituted quinazolinones as angiotensin II antagonists |
02/06/1991 | EP0411754A2 Medicament for the inhibition of interleukin-1 or tumor necrosis factor production by monocytes and/or macrophages |
02/06/1991 | EP0411751A1 Renin inhibitory peptides |
02/06/1991 | EP0411736A1 11-Beta substituted 16-alpha, 17-alpha-methylene-estra-4,9-dien-3-one |
02/06/1991 | EP0411735A1 Cycloalkylenazoles, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicines |
02/06/1991 | EP0411734A1 11-Beta-Aryl-16,16-alpha-cyclohexano-estra-4,9-diene progesterone inhibitors |
02/06/1991 | EP0411733A2 11-Beta-aryle-gona-4,9-dien-3-ones |
02/06/1991 | EP0411705A1 Imidazole compounds and their use as transglutaminase inhibitors |
02/06/1991 | EP0411704A1 Substituted aromatic sulfonamides as antiglaucoma agents |
02/06/1991 | EP0411703A1 Novel HMG-COA synthase inhibitors |
02/06/1991 | EP0411702A1 4-(2-methyl-2-hydroxypropyl-amino)-5,6-dihydrothieno-2(2,3-B)thiopyran-2-sulfonamide-7,7-dioxide |
02/06/1991 | EP0411701A2 Certain imidazole compounds as transglutaminase inhibitors |
02/06/1991 | EP0411668A2 Central cholecystokinin antagonists for treatment of psychiatric disorders |
02/06/1991 | EP0411664A2 2-(2-Vinylpyrrolidinylthio)carbapenem derivatives |
02/06/1991 | EP0411636A2 Piperidylthiocarbapenem derivatives |
02/06/1991 | EP0411631A1 Anti-psychotic compounds |
02/06/1991 | EP0411624A2 Saccharide derivatives of protocatechualdehyde |
02/06/1991 | EP0411619A1 Formulations of phenytoin sodium for intravenous administration |
02/06/1991 | EP0411616A1 4-(N-substituted amino)-2-butynyl-1-carbamates and thiocarbamates and derivatives thereof as centrally acting muscarinic agents |
02/06/1991 | EP0411615A1 4-(N-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents |
02/06/1991 | EP0411593A2 Use of bis (aminothiocarbonyl) disulfide for treating ulcer |
02/06/1991 | EP0411590A2 Method and preparation for reducing risk of myocardial infarction |
02/06/1991 | EP0411567A1 5-(omega-Aminoacyl)-5,10-dihydro-11H-dibenzo[b,e][1,4]-diazepin-11-ones, processes for their preparation, and their use as medicaments |
02/06/1991 | EP0411541A2 Process for preparing monobactames and their intermediate product |
02/06/1991 | EP0411534A2 Derivatives of 1,2,3,4-tetrahydro-9-acridinamine |
02/06/1991 | EP0411420A2 Imino substituted pyridine |
02/06/1991 | EP0411419A2 Substituted thienopyranones, process for their preparation and their use in combating parasites |
02/06/1991 | EP0411395A2 Use of ACE inhibitors for atherosclerosis-prophylaxis |
02/06/1991 | EP0411394A1 Imidazoquinolone derivates |
02/06/1991 | EP0411315A1 Aqueous antiseptic composition |
02/06/1991 | EP0411268A2 Dibenzo(1,5)dioxocin-5-on derivatives, their use in medicines and process for their preparation |
02/06/1991 | EP0411184A1 Ascorbic acid derivative |
02/06/1991 | EP0411183A1 Ascorbic acid derivative |
02/06/1991 | EP0411182A1 Ascorbic acid derivative |
02/06/1991 | EP0411111A1 Ammonium compound, composition containing it and desinfection method. |
02/06/1991 | EP0411048A1 Novel benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use |
02/06/1991 | EP0233946B1 Chromoglycic acid derivatives, process for their preparation, and medicinal composition |
02/06/1991 | CN1049015A 14.17 alpha-ethenylidene and bridging ethidene estratriene and process for preparing same and use in preparing pharmaceutical |
02/06/1991 | CN1048980A Intraocular pressure reducing 11, 15-diacyl prostaglandins |
02/06/1991 | CN1048979A Compositions and in situ methods for forming films |
02/06/1991 | CN1011507B Processes for preparing 1,3-oxazolidine-2-one derivatives |
02/06/1991 | CA2022693A1 Chroman derivatives |
02/06/1991 | CA2022692A1 Renin inhibitors |
02/06/1991 | CA2022633A1 Compounds |
02/06/1991 | CA2022632A1 Pharmaceutical formulation |
02/05/1991 | USRE33533 Polycyclic heterocyclic compounds, a process for their preparation and their use in human and veterinary medicine |
02/05/1991 | US4990703 Novel tetrahydronaphthalene and indane derivatives |
02/05/1991 | US4990664 Ethanolamine derivatives |
02/05/1991 | US4990646 Preparation of halogenated quinolonecarboxylic acids |
02/05/1991 | US4990635 Synthesis of 6-methylene derivatives of androsta-1,4-diene-3,17-dione |
02/05/1991 | US4990619 Pyrazoline derivatives |
02/05/1991 | US4990614 Glutamate receptor inhibitors |
02/05/1991 | US4990610 Reacting Sucrose with Chlorosulfonic acid and 2-Picoline |
02/05/1991 | US4990606 Stable sulpho-adenosyl-L-methionine (SAMe) salts, particularly suitable for parenteral use |
02/05/1991 | US4990538 Administering for the treatment of cancer |
02/05/1991 | US4990537 6-amidinonaphth-2-yl or p-(n,n-dimethylcarbamoyl methoxy-carbonyl methyl) phenyl ester of p-guanidinobenzoic acid |
02/05/1991 | US4990535 Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
02/05/1991 | US4990534 Aralkyl esters and processes for their preparation |
02/05/1991 | US4990531 Derivatives of 1-arylsulphonyl-2-pyrrolidinone and their use as medicaments |
02/05/1991 | US4990530 Indomethacin injections and their production method |
02/05/1991 | US4990529 Pyrazolone derivatives for treating cerebrovascular diseases |
02/05/1991 | US4990524 2-thiazolones in a method of treating a gastric ulcer |
02/05/1991 | US4990523 Treatment of chronic inflammatory joint disease with arylsulfonamides |
02/05/1991 | US4990522 Esterified ephedrine derivatives with prolonged antiulcer activity |
02/05/1991 | US4990518 Pharmacologically active heteroaryl substituted imidazo (4,5-c) pyridines |
02/05/1991 | US4990517 7-(1-pyrrolidinyl)-3-quinolone- and -naphthyridonecarboxylic acid derivatives as antibacterial agents and feed additives |
02/05/1991 | US4990516 Ameliorating agent for dysmnesia |
02/05/1991 | US4990515 Chemical intermediates |
02/05/1991 | US4990513 2-oxo-pyrrolidine-1-acetamide and orotic acid or salts; cerebro-and hepatoprotective |
02/05/1991 | US4990510 Substituted indoloquinoxalines |
02/05/1991 | US4990509 Sulfonamide anti-arrhythmic agents |
02/05/1991 | US4990508 Reduced side effects |
02/05/1991 | US4990505 Phenethanolamine compounds |
02/05/1991 | US4990501 Film forming composition for topical use |
02/05/1991 | US4990341 Analgesics; time-release agents |
02/05/1991 | US4990338 Antimicrobial superabsorbent compositions and methods |
02/05/1991 | US4990333 Treating with isolated omental lipid containing gangliosides |
02/05/1991 | US4990329 Toothpaste or mouthrinse containing monoperphthalate; preventing anaerobic infections; topical |
02/05/1991 | US4990328 Phosphoictrate |
02/05/1991 | US4990289 1-palmityl, 2-butyryl-di-glyceride and 1-stearyl, 2-butyryl-di-glyceride mixture isolatedd from milk; phorbol competition |
02/05/1991 | CA2022462A1 Aminoketone derivatives and use thereof |
02/05/1991 | CA2022460A1 Benzothiazimig derivatives, their preparation and applications as medicaments or as intermediates in the systhesis of medicaments |
02/05/1991 | CA1279872C Cycloalkyl diphosphonic acid compounds and pharmaceutically-acceptable salts and esters thereof |
02/05/1991 | CA1279870C Aroyl substituted dihydro-1,4-thiazines |